This developer of single-use medical devices for use in minimally invasive cardiovascular procedures has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Spectranetics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some notable stocks in the medical instruments industry are Heartware International Inc. (HTWR), IDEXX Laboratories, Inc. (IDXX) and Sirona Dental Systems Inc. (SIRO). All the three stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment